Market Research Logo

Canine Arthritis Treatment Market: Asia Pacific Excluding Japan to Register the Fastest Growth During the Forecast Period: Global Industry Analysis (2013 - 2017) and Opportunity Assessment (2018 - 2028)

Canine Arthritis Treatment Market: Asia Pacific Excluding Japan to Register the Fastest Growth During the Forecast Period: Global Industry Analysis (2013 - 2017) and Opportunity Assessment (2018 - 2028)

Future Market Insights (FMI) offers a 10-year forecast on the global canine arthritis treatment market. The primary objective of the report is to offer updates and information related to market opportunities in the canine arthritis treatment market.

Report Description

In terms of revenue, the global canine arthritis treatment market is expected to register a CAGR of 4.4% during the forecast period, 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global canine arthritis treatment market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global canine arthritis treatment market are presented in the report.

The global market for canine arthritis treatment is expected to witness high growth rate in terms of value in high economic countries due to fast FDA approvals for novel and innovative canine arthritis treatment drugs coupled with growing adoption of stem therapy to treat arthritis. Additionally, huge investments in the research and development sector for the development of advanced stem cell therapy and drugs for arthritis in countries such as the U.S., Germany, France and U.K. is expected to create numerous opportunities for the manufacturers of canine arthritis treatment products. Manufacturers are focusing on the production of high-grade drugs with less side effects due to its high demand from end users.

The report includes canine arthritis treatment drugs such as non-steroidal anti-inflammatory medications (NSAIDs) and opioids. Also, the stem cell therapy is taken into account along with drugs to calculate revenue generation in the canine arthritis treatment market.

However, the report does not include revenue generated by the sale of other medical products such as prosthetics and medical devices. Currency fluctuations and inflation are not considered while calculating the revenue of the canine arthritis treatment market

Revenue from the canine arthritis treatment market in North America is expected to expand at the relatively higher CAGR due to growing adoption of drugs and therapies and increased consumer spending on veterinary care. To understand and assess the opportunities in this market, the report offers the market forecast on the basis of segment type classified into the treatment type, route of administration, end users and regions. The report provides analysis of the global canine arthritis treatment market in terms of market value (US$ Mn).

The global canine arthritis treatment market is segmented on the basis of treatment type into:

Non-steroidal anti-inflammatory drugs
Opioids
Stem Cell Therapy
The report begins with the market definition of canine arthritis treatment, followed by definitions of the different treatment types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global canine arthritis treatment market.

The report analyses the canine arthritis treatment market on the basis of the route of administration and end users and presents forecast in terms of value for the next 10 years. On the basis of route of administration, the global canine arthritis treatment market is segmented into:

Oral

Injectable

On the basis of the end users, the global canine arthritis treatment market is segmented into:

Veterinary Hospitals and Clinics

Retail Pharmacies

Drug Stores

E-commerce

Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of region, the global canine arthritis treatment market is segmented into:

North America

U.S.

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Europe

Germany

France

U.K.

Italy

Spain

Russia

Rest of Europe

Asia Pacific

India

China

Australia & New Zealand

ASEAN

Rest of APEJ

Japan

Middle East & Africa (MEA)

GCC Countries

South Africa

Rest of MEA

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global canine arthritis treatment market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by the canine arthritis treatment market. To understand the key segments in terms of their growth and performance in the global canine arthritis treatment market, Future Market Insights has developed a market attractiveness index. The resulting index will help identify the existing market opportunities in canine arthritis treatment market.

In the final section of the report, a ‘competitive landscape’ has been included to provide a dashboard view of the key companies operating in the global canine arthritis treatment market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the canine arthritis treatment market. However, this section also includes market strategies and SWOT analysis of the key players operating in the global canine arthritis treatment market.

Detailed profiles of canine arthritis treatment drug manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies. Examples of some of the key players operating in the canine arthritis treatment market are Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc., Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc., Norbrook Laboratories Limited, VetStem Biopharma, and Dechra Pharmaceuticals Plc, among others.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Company Description and Canine Arthritis Treatment Market Research Coverage
3. Canine Arthritis Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Technology Evolution
4.2. List of Growth Hacking Manufacturers
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Regulatory Scenario
5. Global Economic Outlook
5.1. Canine Arthritis Treatment Market Outlook
6. Key Inclusions
6.1. Canine Arthritis Treatment Market Analysis
6.2. Canine Osteoarthritis Treatment Scenario
7. North America Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
7.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
7.4.2. Opioids
7.4.3. Stem Cell Therapy
7.4.3.1. Allogeneic Stem Cell
7.4.3.2. Autologous Stem Cell
7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
7.6.1. Oral
7.6.2. Injectable
7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
7.8.1. Veterinary Hospitals & Clinics
7.8.2. Retail Pharmacies
7.8.3. Drug Stores
7.8.4. E-commerce
7.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
7.10.Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Treatment Type
7.10.3. By Route of Administration
7.10.4. By End User
7.11.Drivers and Restraints: Impact Analysis
7.12.Key Market Participants – Intensity Mapping
8. Latin America Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
8.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
8.4.2. Opioids
8.4.3. Stem Cell Therapy
8.4.3.1. Allogeneic Stem Cell
8.4.3.2. Autologous Stem Cell
8.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
8.6.1. Oral
8.6.2. Injectable
8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
8.8.1. Veterinary Hospitals & Clinics
8.8.2. Retail Pharmacies
8.8.3. Drug Stores
8.8.4. E-commerce
8.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
8.10.Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Treatment Type
8.10.3. By Route of Administration
8.10.4. By End User
8.11.Drivers and Restraints: Impact Analysis
8.12. Key Market Participants – Intensity Mapping
9. Europe Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
9.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
9.4.2. Opioids
9.4.3. Stem Cell Therapy
9.4.3.1. Allogeneic Stem Cell
9.4.3.2. Autologous Stem Cell
9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
9.6.1. Oral
9.6.2. Injectable
9.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
9.8.1. Veterinary Hospitals & Clinics
9.8.2. Retail Pharmacies
9.8.3. Drug Stores
9.8.4. E-commerce
9.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
9.10.Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Treatment Type
9.10.3. By Route of Administration
9.10.4. By End User
9.11.Drivers and Restraints: Impact Analysis
9.12.Key Market Participants – Intensity Mapping
10. Asia Pacific Excluding Japan (APEJ) Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
10.1.Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
10.2.1. China
10.2.2. India
10.2.3. Australia and New Zealand
10.2.4. ASEAN
10.2.5. Rest of APEJ
10.3.Market Size (US$ Mn) Forecast By Country, 2018-2028
10.4.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
10.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
10.4.2. Opioids
10.4.3. Stem Cell Therapy
10.4.3.1. Allogeneic Stem Cell
10.4.3.2. Autologous Stem Cell
10.5.Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
10.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
10.6.1. Oral
10.6.2. Injectable
10.7.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
10.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
10.8.1. Veterinary Hospitals & Clinics
10.8.2. Retail Pharmacies
10.8.3. Drug Stores
10.8.4. E-commerce
10.9.Market Size (US$ Mn) Forecast By End User, 2018-2028
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Treatment Type
10.10.3. By Route of Administration
10.10.4. By End User
10.11. Drivers and Restraints: Impact Analysis
10.12. Key Market Participants – Intensity Mapping
11. Japan Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
11.1.Introduction
11.2.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
11.2.1. Non-steroidal anti-inflammatory medications (NSAIDs)
11.2.2. Opioids
11.2.3. Stem Cell Therapy
11.2.3.1. Allogeneic Stem Cell
11.2.3.2. Autologous Stem Cell
11.3.Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
11.4.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
11.4.1. Oral
11.4.2. Injectable
11.5.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
11.6.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
11.6.1. Veterinary Hospitals & Clinics
11.6.2. Retail Pharmacies
11.6.3. Drug Stores
11.6.4. E-commerce
11.7.Market Size (US$ Mn) Forecast By End User, 2018-2028
11.8.Market Attractiveness Analysis
11.8.1. By Treatment Type
11.8.2. By Route of Administration
11.8.3. By End User
11.9.Drivers and Restraints: Impact Analysis
11.10. Key Market Participants – Intensity Mapping
12. Middle East and Africa Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
12.1.Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of Middle East and Africa
12.3.Market Size (US$ Mn) Forecast By Country, 2018-2028
12.4.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
12.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
12.4.2. Opioids
12.4.3. Stem Cell Therapy
12.4.3.1. Allogeneic Stem Cell
12.4.3.2. Autologous Stem Cell
12.5.Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
12.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
12.6.1. Oral
12.6.2. Injectable
12.7.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
12.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
12.8.1. Veterinary Hospitals & Clinics
12.8.2. Retail Pharmacies
12.8.3. Drug Stores
12.8.4. E-commerce
12.9.Market Size (US$ Mn) Forecast By End User, 2018-2028
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Treatment Type
12.10.3. By Route of Administration
12.10.4. By End User
12.11. Drivers and Restraints: Impact Analysis
12.12. Key Market Participants – Intensity Mapping
13. Forecast Factors: Relevance and Impact
14. Forecast Assumptions
15. Competition Analysis
15.1.Competition Dashboard
15.2.Company Deep Dive
15.2.1. Elanco (Eli Lily and Company)
15.2.1.1. Overview
15.2.1.2. Product and Application Portfolio
15.2.1.3. Production Footprint
15.2.1.4. Sales Footprint
15.2.1.5. Channel Footprint
15.2.1.6. Strategy
15.2.1.6.1. Marketing Strategy
15.2.1.6.2. Product Strategy
15.2.1.6.3. Channel Strategy
15.2.2. Ceva Santé Animale
15.2.2.1. Overview
15.2.2.2. Product and Application Portfolio
15.2.2.3. Production Footprint
15.2.2.4. Sales Footprint
15.2.2.5. Channel Footprint
15.2.2.6. Strategy
15.2.2.6.1. Marketing Strategy
15.2.2.6.2. Product Strategy
15.2.2.6.3. Channel Strategy
15.2.3. Vetoquinol S.A.
15.2.3.1. Overview
15.2.3.2. Product and Application Portfolio
15.2.3.3. Production Footprint
15.2.3.4. Sales Footprint
15.2.3.5. Channel Footprint
15.2.3.6. Strategy
15.2.3.6.1. Marketing Strategy
15.2.3.6.2. Product Strategy
15.2.3.6.3. Channel Strategy
15.2.4. Norbrook Laboratories Limited
15.2.4.1. Overview
15.2.4.2. Product and Application Portfolio
15.2.4.3. Production Footprint
15.2.4.4. Sales Footprint
15.2.4.5. Channel Footprint
15.2.4.6. Strategy
15.2.4.6.1. Marketing Strategy
15.2.4.6.2. Product Strategy
15.2.4.6.3. Channel Strategy
15.2.5. Aratana Therapeutics Inc.
15.2.5.1. Overview
15.2.5.2. Product and Application Portfolio
15.2.5.3. Production Footprint
15.2.5.4. Sales Footprint
15.2.5.5. Channel Footprint
15.2.5.6. Strategy
15.2.5.6.1.1. Marketing Strategy
15.2.5.6.1.2. Product Strategy
15.2.5.6.1.3. Channel Strategy
15.2.6. Boehringer Ingelheim
15.2.6.1. Overview
15.2.6.2. Product and Application Portfolio
15.2.6.3. Production Footprint
15.2.6.4. Sales Footprint
15.2.6.5. Channel Footprint
15.2.6.6. Strategy
15.2.6.6.1. Marketing Strategy
15.2.6.6.2. Product Strategy
15.2.6.6.3. Channel Strategy
15.2.7. Zoetis Inc.
15.2.7.1. Overview
15.2.7.2. Product and Application Portfolio
15.2.7.3. Production Footprint
15.2.7.4. Sales Footprint
15.2.7.5. Channel Footprint
15.2.7.6. Strategy
15.2.7.6.1. Marketing Strategy
15.2.7.6.2. Product Strategy
15.2.7.6.3. Channel Strategy
15.2.8. Bayer AG
15.2.8.1. Overview
15.2.8.2. Product and Application Portfolio
15.2.8.3. Production Footprint
15.2.8.4. Sales Footprint
15.2.8.5. Channel Footprint
15.2.8.6. Strategy
15.2.8.6.1. Marketing Strategy
15.2.8.6.2. Product Strategy
15.2.8.6.3. Channel Strategy
15.2.9. VetStem Biopharma
15.2.9.1. Overview
15.2.9.2. Product and Application Portfolio
15.2.9.3. Production Footprint
15.2.9.4. Sales Footprint
15.2.9.5. Channel Footprint
15.2.9.6. Strategy
15.2.9.6.1. Marketing Strategy
15.2.9.6.2. Product Strategy
15.2.9.6.3. Channel Strategy
15.2.10. Dechra Pharmaceuticals PLC
15.2.10.1. Overview
15.2.10.2. Product and Application Portfolio
15.2.10.3. Production Footprint
15.2.10.4. Sales Footprint
15.2.10.5. Channel Footprint
15.2.10.6. Strategy
15.2.10.6.1. Marketing Strategy
15.2.10.6.2. Product Strategy
15.2.10.6.3. Channel Strategy
16. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028 By Region
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Mn) Analysis By Region
16.2.1. North America
16.2.2. Latin America
16.2.3. Europe
16.2.4. Asia Pacific Excluding Japan
16.2.5. Japan
16.2.6. Middle East and Afica
16.3. Market Size (US$ Mn) Forecast By Region, 2018-2028
16.4. Market Attractiveness Analysis By Region
17. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
17.1. Introduction/Key Finding
17.2.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
17.2.1. Non-steroidal anti-inflammatory medications (NSAIDs)
17.2.2. Opioids
17.2.3. Stem Cell Therapy
17.2.3.1. Allogeneic Stem Cell
17.2.3.2. Autologous Stem Cell
17.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
17.4. Market Attractiveness Analysis By Treatment Type
18. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
18.1. Introduction/Key Finding
18.2.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
18.2.1. Oral
18.2.2. Injectable
18.3. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
18.4. Market Attractiveness Analysis By Route of Administration
19. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By End User
19.1.Introduction/Key Finding
19.2.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
19.2.1. Veterinary Hospitals & Clinics
19.2.2. Retail Pharmacies
19.2.3. Drug Stores
19.2.4. E-commerce
19.3.Market Size (US$ Mn) Forecast By End User, 2018-2028
19.4.Market Attractiveness Analysis By End User
20. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
20.1.Market Value Share Analysis By All Segment
20.2.Y-o-Y Growth Analysis By All Segment
20.3.Absolute $ Opportunity
21. Assumptions and Acronyms Used
22. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report